HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,523 | +11.7% | 454 | -0.7% | 0.00% | 0.0% |
| Q2 2023 | $47,002 | -5.8% | 457 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $49,877 | -4.1% | 457 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $52,007 | +79.3% | 457 | -0.9% | 0.00% | +100.0% |
| Q3 2022 | $29,000 | +26.1% | 461 | +56.8% | 0.00% | 0.0% |
| Q2 2022 | $23,000 | -46.5% | 294 | -27.9% | 0.00% | -50.0% |
| Q1 2022 | $43,000 | +59.3% | 408 | +65.9% | 0.00% | +100.0% |
| Q4 2021 | $27,000 | -25.0% | 246 | -25.2% | 0.00% | 0.0% |
| Q3 2021 | $36,000 | +50.0% | 329 | +29.5% | 0.00% | 0.0% |
| Q2 2021 | $24,000 | +14.3% | 254 | +11.4% | 0.00% | 0.0% |
| Q1 2021 | $21,000 | +133.3% | 228 | +94.9% | 0.00% | – |
| Q4 2020 | $9,000 | +12.5% | 117 | +20.6% | 0.00% | – |
| Q3 2020 | $8,000 | +166.7% | 97 | +70.2% | 0.00% | – |
| Q2 2020 | $3,000 | +200.0% | 57 | -8.1% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 62 | +8.8% | 0.00% | – |
| Q4 2019 | $2,000 | -93.3% | 57 | -94.8% | 0.00% | -100.0% |
| Q3 2019 | $30,000 | +20.0% | 1,105 | +4.5% | 0.00% | +50.0% |
| Q2 2019 | $25,000 | – | 1,057 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |